New issues in tuberculosis

Annals of the Rheumatic Diseases

Volumn 63, Issue SUPPL. 2, 2004, Pages

  Kaufmann, S H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GLYCOLIPID;

BACTERIAL CELL WALL; BACTERIAL STRAIN; CONFERENCE PAPER; DRUG DESIGN; HUMAN; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MACROPHAGE; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

BCG VACCINE; EUROPE; HUMANS; IMMUNITY, CELLULAR; TUBERCULOSIS; VACCINES, SYNTHETIC;

EID: 7044262743     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.028258     Document Type: Conference Paper

References (19)

1. World Health Organization. Global atlas of infectious diseases. Geneva: WHO International, 2004.
2. Kaufmann SHE. Is the development of a new tuberculosis vaccine possible? Nat Med 2000;6:955-60.
3. Kaufmann SHE. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001;1:20-30.
4. Stewart GR, Robertson BD, Young DB. Tuberculosis: a problem with persistence. Nat Rev Microbiol 2003;1:97-105.
5. Shen Y, Zhou DJ, Qiu LY, Lai XM, Simon M, Shen L, et al. Adaptive immune response of V gomma 2V delta 2(+) T cells during mycobacterial infections. Science 2002;295:2255-8.
6. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR Jr. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 2003;4:949-55.
7. den Haan JM, Bevan MJ. Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr Opin Immunol 2001;13:437-41.
8. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003;425:397-402.
9. Houde M, Bertholet S, Gagnon E, Brunei S, Goyette G, Laplante A, et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003;425:402-6.
10. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 2003;9:1039-46.
11. Winau F, Schwierzeck V, Hurwitz R, Remmel N, Sieling PA, Modlin RL, et al. Saposin C is required for lipid presentation by human CD1b. Nat Immunol 2004;5:169-74.
12. Kang SJ, Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 2004;5:175-81.
13. Zhou D, Cantu C III, Sagiv Y, Schrantz N, Kulkarni AB, Qi X, et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 2004;303:523-7.
14. Fine PEM. The BCG story-lessons from the past and implications for the future. Rev Infect Dis 1989;11:S353-S359.
15. Kaufmann SHE. In: Kaufmann SHE, ed. Novel vaccination strategies. Weinheim: Wiley-VCH, 2004.
16. Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J, et al. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999;33:1103-17.
17. Mattow J, Schaible UE, Schmidt F, Hagens K, Siejak F, Brestrich G, et al. Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 2003;24:3405-20.
18. Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SHE. Mycobacterium bavis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA 1998;95:5299-304.
19. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002;8:843-9.